Passage Bio (PASG) Competitors $0.66 +0.01 (+0.92%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PASG vs. TSVT, HURA, NKTX, CKPT, SCPH, ZURA, VTYX, CDTX, TCRX, and NBTXShould you be buying Passage Bio stock or one of its competitors? The main competitors of Passage Bio include 2seventy bio (TSVT), TuHURA Biosciences (HURA), Nkarta (NKTX), Checkpoint Therapeutics (CKPT), scPharmaceuticals (SCPH), Zura Bio (ZURA), Ventyx Biosciences (VTYX), Cidara Therapeutics (CDTX), TScan Therapeutics (TCRX), and Nanobiotix (NBTX). These companies are all part of the "pharmaceutical products" industry. Passage Bio vs. 2seventy bio TuHURA Biosciences Nkarta Checkpoint Therapeutics scPharmaceuticals Zura Bio Ventyx Biosciences Cidara Therapeutics TScan Therapeutics Nanobiotix 2seventy bio (NASDAQ:TSVT) and Passage Bio (NASDAQ:PASG) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, community ranking, profitability, dividends, earnings and media sentiment. Which has better valuation & earnings, TSVT or PASG? Passage Bio has lower revenue, but higher earnings than 2seventy bio. 2seventy bio is trading at a lower price-to-earnings ratio than Passage Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio2seventy bio$45.62M3.55-$217.57M-$1.86-1.69Passage BioN/AN/A-$102.06M-$1.17-0.56 Do analysts rate TSVT or PASG? 2seventy bio currently has a consensus target price of $9.00, suggesting a potential upside of 186.62%. Passage Bio has a consensus target price of $7.75, suggesting a potential upside of 1,074.24%. Given Passage Bio's stronger consensus rating and higher possible upside, analysts clearly believe Passage Bio is more favorable than 2seventy bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 2seventy bio 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.56Passage Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TSVT or PASG more profitable? Passage Bio has a net margin of 0.00% compared to 2seventy bio's net margin of -207.25%. 2seventy bio's return on equity of -53.65% beat Passage Bio's return on equity.Company Net Margins Return on Equity Return on Assets 2seventy bio-207.25% -53.65% -23.67% Passage Bio N/A -72.53%-52.10% Which has more risk & volatility, TSVT or PASG? 2seventy bio has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500. Comparatively, Passage Bio has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Do insiders & institutionals have more ownership in TSVT or PASG? 93.9% of 2seventy bio shares are held by institutional investors. Comparatively, 53.5% of Passage Bio shares are held by institutional investors. 7.2% of 2seventy bio shares are held by insiders. Comparatively, 4.3% of Passage Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer TSVT or PASG? Passage Bio received 27 more outperform votes than 2seventy bio when rated by MarketBeat users. Likewise, 68.42% of users gave Passage Bio an outperform vote while only 56.82% of users gave 2seventy bio an outperform vote. CompanyUnderperformOutperform2seventy bioOutperform Votes2556.82% Underperform Votes1943.18% Passage BioOutperform Votes5268.42% Underperform Votes2431.58% Does the media prefer TSVT or PASG? In the previous week, 2seventy bio had 1 more articles in the media than Passage Bio. MarketBeat recorded 1 mentions for 2seventy bio and 0 mentions for Passage Bio. Passage Bio's average media sentiment score of 0.00 beat 2seventy bio's score of -1.00 indicating that Passage Bio is being referred to more favorably in the news media. Company Overall Sentiment 2seventy bio Negative Passage Bio Neutral SummaryPassage Bio beats 2seventy bio on 9 of the 17 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PASG vs. The Competition Export to ExcelMetricPassage BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$40.40M$2.94B$5.14B$9.08BDividend YieldN/A1.90%5.09%4.23%P/E Ratio-0.5646.7390.0517.18Price / SalesN/A415.011,117.14116.99Price / CashN/A182.1043.0437.86Price / Book0.333.894.784.78Net Income-$102.06M-$42.21M$120.31M$225.60M7 Day Performance-13.04%-2.15%-1.92%-1.23%1 Month Performance23.13%4.20%11.51%3.36%1 Year Performance-27.63%18.39%30.61%16.60% Passage Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PASGPassage Bio2.6838 of 5 stars$0.66+0.9%$7.75+1,074.2%-19.0%$40.40MN/A-0.56130High Trading VolumeTSVT2seventy bio2.2124 of 5 stars$3.30+0.9%$9.00+172.7%-7.1%$170.25M$100.39M-1.76440Positive NewsHURATuHURA BiosciencesN/A$3.97-19.5%$15.00+277.8%N/A$167.87MN/A0.00N/AAnalyst ForecastNews CoverageNKTXNkarta2.7945 of 5 stars$2.36+0.9%$15.00+535.6%-35.4%$166.54MN/A-1.24140Gap UpCKPTCheckpoint Therapeutics3.8163 of 5 stars$3.37-8.2%$10.33+206.6%+113.1%$164.56M$100,000.00-1.8310Insider TradeNews CoverageGap UpHigh Trading VolumeSCPHscPharmaceuticals3.2494 of 5 stars$3.27+2.5%$15.00+358.7%-43.6%$163.63M$13.59M-1.6830ZURAZura Bio3.2143 of 5 stars$2.50+9.6%$15.80+532.0%-52.8%$163.23MN/A0.003VTYXVentyx Biosciences2.9157 of 5 stars$2.30+0.9%$10.00+334.8%+7.7%$162.63MN/A-0.9773CDTXCidara Therapeutics3.6797 of 5 stars$23.00+0.5%$32.20+40.0%+54.8%$162.15M$63.90M-0.9090TCRXTScan Therapeutics2.1783 of 5 stars$3.00+5.3%$11.25+275.0%-38.6%$160.11M$21.05M-2.69100NBTXNanobiotix2.0828 of 5 stars$3.34+0.3%$12.00+259.3%-53.3%$157.42M$36.22M0.00100News CoverageGap Up Related Companies and Tools Related Companies TSVT Alternatives HURA Alternatives NKTX Alternatives CKPT Alternatives SCPH Alternatives ZURA Alternatives VTYX Alternatives CDTX Alternatives TCRX Alternatives NBTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PASG) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Passage Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PASG Stock Alerts